BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+0.82%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$22.8B
AUM Growth
+$22.8B
Cap. Flow
+$265M
Cap. Flow %
1.16%
Top 10 Hldgs %
82.65%
Holding
132
New
12
Increased
20
Reduced
6
Closed
10

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$160M
2
PACB icon
Pacific Biosciences
PACB
$57.3M
3
KOD icon
Kodiak Sciences
KOD
$52.2M
4
TVTX icon
Travere Therapeutics
TVTX
$44.9M
5
BLUE
bluebird bio
BLUE
$43.4M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$144M
2
ADCT icon
ADC Therapeutics
ADCT
$34.5M
3
AMRN
Amarin Corp
AMRN
$23.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
$20.4M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
$13.3M

Sector Composition

1 Healthcare 97.89%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DBVT
26
DBV Technologies
DBVT
$249M
$71.6M 0.31%
14,614,264
– –
TIL icon
27
Instil Bio
TIL
$196M
$69.6M 0.31%
3,893,700
– –
VERV
28
DELISTED
Verve Therapeutics
VERV
$66.6M 0.29%
1,416,530
– –
VSTM icon
29
Verastem
VSTM
$585M
$66.2M 0.29%
21,491,630
– –
HZNP
30
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$65.6M 0.29%
599,110
– –
NBIX icon
31
Neurocrine Biosciences
NBIX
$13.5B
$64.9M 0.29%
676,975
– –
INSM icon
32
Insmed
INSM
$30.3B
$59.4M 0.26%
2,156,001
– –
IMTX icon
33
Immatics
IMTX
$662M
$57.5M 0.25%
4,423,731
+140,793
+3% +$1.83M
ADAP
34
Adaptimmune Therapeutics
ADAP
$13.9M
$50.8M 0.22%
9,830,877
– –
RYTM icon
35
Rhythm Pharmaceuticals
RYTM
$6.75B
$50.5M 0.22%
3,863,239
– –
ZYME icon
36
Zymeworks
ZYME
$1.07B
$49.6M 0.22%
1,708,472
– –
TVTX icon
37
Travere Therapeutics
TVTX
$1.75B
$49.5M 0.22%
2,039,772
+1,852,857
+991% +$44.9M
BLUE
38
DELISTED
bluebird bio
BLUE
$47.8M 0.21%
2,499,715
+2,272,727
+1,001% +$43.4M
TLIS
39
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$47.3M 0.21%
7,574,835
– –
FMTX
40
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$47M 0.21%
2,024,876
– –
MRUS icon
41
Merus
MRUS
$5.04B
$44.8M 0.2%
2,037,469
– –
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$3.04B
$40.1M 0.18%
444,444
– –
ALKS icon
43
Alkermes
ALKS
$4.95B
$37.9M 0.17%
1,228,170
– –
FLGT icon
44
Fulgent Genetics
FLGT
$674M
$36.1M 0.16%
401,016
– –
JBIO
45
Jade Biosciences, Inc. Common Stock
JBIO
$245M
$34.7M 0.15%
1,652,171
+223,600
+16% +$4.69M
ALGS icon
46
Aligos Therapeutics
ALGS
$75.1M
$32.2M 0.14%
2,076,400
+466,400
+29% +$7.23M
KNSA icon
47
Kiniksa Pharmaceuticals
KNSA
$2.63B
$31.9M 0.14%
2,799,577
– –
KRYS icon
48
Krystal Biotech
KRYS
$4.35B
$31.7M 0.14%
607,735
– –
NGNE icon
49
Neurogene
NGNE
$284M
$27.6M 0.12%
3,821,740
– –
SYRE icon
50
Spyre Therapeutics
SYRE
$1.02B
$27.1M 0.12%
3,410,106
– –
1
2
3 4 5